The article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.
Source
U.S. Food and Drug Administration (FDA)
Year
Format
Advisory
Terms of Use
Public domain
Topic
Emergency Departments
Audience
Medical Providers
First Responders
Resource Type
Web Page
Use
Overdose
Special Collection
MAT Tools and Resources
